Skip to content
facebook
twitter
linkedin
youtube
Toggle navigation
L36, 1 Macquarie Place, Sydney, NSW 2000
+61 2 8051 3043
info@raceoncology.com
Home
About
Science
Management team
Investors
News
CONTACT US
×
Contact Us
Δ
September 2022 Quarterly Activity Report & Appendix 4C
Browse
Home
Featured
September 2022 Quarterly Activity Report & Appendix 4C
27
Oct
Oct
, 27 ,
2022
Daniel Tillett
September-2022-Quarterly-Activity-Report-and-Appendix-4C
Download
Facebook
Tweet
LinkedIn
Related posts:
Pitt Street Research Initiates Coverage of Race Oncology
Race Oncology June 2022 Quarterly Investor Briefing
Race Receives Human Ethics Approval for Extramedullary AML & MDS Trial
Post navigation
Previous
Previous post:
Next
Next post:
Race Oncology
Targeting Zantrene® towards better cancer outcomes
Contact Us
©2023 Race Oncology Ltd |
Privacy Policy